Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leukocyte Antigen-C (HLA-C) Allorecognition Patterns in Women with Endometriosis

Overview

Journal Sci Rep

Specialty Science

Date 2020 Mar 19

PMID 32184413

Citations 12

Authors

Ya-Ching Chou

Chi-Huang Chen

Ming-Jer Chen

Ching-Wen Chang

Pi-Hua Chen

Mu-Hsien Yu

Yi-Jen Chen

Eing-Mei Tsai

Peng-Sheng Yang

Shyr-Yeu Lin

Chii-Ruey Tzeng

Affiliations

Soon will be listed here.

Abstract

Endometriosis shares similarities with several autoimmune diseases. The human leukocyte antigen (HLA)-C genotype is associated with several human autoimmune diseases. HLA-C is a ligand of killer cell immunoglobulin receptors (KIRs) and is an essential regulator of natural killer cell activity, which is associated with endometriosis progression. Polymorphisms in HLA-C and KIR affect the activity of NK cells and susceptibility to several diseases. Therefore, we attempted to investigate an association between HLA-C genotype and KIR polymorphism and the occurrence of endometriosis. We tested the association of certain KIR and HLA-C combinations and the development of endometriosis by characterizing both KIR and HLA-C genes in 147 women with endometriosis and 117 controls. The HLA-C genotypes and KIR polymorphisms were analyzed via DNA-based method for higher-resolution genotyping. We found that the occurrence of HLA-C*03:03*01 was increased in endometriosis than in control groups. Analysis of various KIR haplotypes revealed differences between the endometriosis and control cohorts. The number of KIR centromeric A/A haplotypes was increased in the endometriosis group than controls. Moreover, the endometriosis cohort was characterized by reduced number of KIR2DS2-positive individuals in the Han Chinese population. Our current findings suggest that the KIR and HLA-C genotypes are associated with the pathogenesis of endometriosis.

Citing Articles

Association of killer immunoglobulin-like receptor genotypes and haplotypes with acute lymphoblastic leukemia risk.

Al-Tamimi J, Alomar S, Aljuaimlani A, Mansour L Innate Immun. 2025; 31:17534259251314774.

PMID: 39828905 PMC: 11774482. DOI: 10.1177/17534259251314774.

Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers.

Vernet-Tomas M, Vazquez I, Olivares F, Lopez D, Yelamos J, Comerma L Breast Cancer (Dove Med Press). 2024; 16:657-666.

PMID: 39387059 PMC: 11463177. DOI: 10.2147/BCTT.S476721.

Evaluation of HLA-DQ2 and HLA-DQ8 haplotypes in patients with endometriosis, A case-control study.

Andres M, Peloggia A, Abrao H, Magalhaes T, Neto J, Abrao M Clinics (Sao Paulo). 2024; 79:100317.

PMID: 38432123 PMC: 10914556. DOI: 10.1016/j.clinsp.2023.100317.

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

Marques Da Costa M, Zaidi S, Scoazec J, Droit R, Lim W, Marchais A Commun Biol. 2023; 6(1):949.

PMID: 37723198 PMC: 10507044. DOI: 10.1038/s42003-023-05320-0.

Identification of molecular subtypes and immune infiltration in endometriosis: a novel bioinformatics analysis and validation.

Lv S, Sun J, Gan L, Sun J Front Immunol. 2023; 14:1130738.

PMID: 37662927 PMC: 10471803. DOI: 10.3389/fimmu.2023.1130738.

References

Rogers P, DHooghe T, Fazleabas A, Gargett C, Giudice L, Montgomery G . Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009; 16(4):335-46. PMC: 3682634. DOI: 10.1177/1933719108330568. View

Giudice L . Clinical practice. Endometriosis. N Engl J Med. 2010; 362(25):2389-98. PMC: 3108065. DOI: 10.1056/NEJMcp1000274. View

Giudice L, Kao L . Endometriosis. Lancet. 2004; 364(9447):1789-99. DOI: 10.1016/S0140-6736(04)17403-5. View

Nnoaham K, Hummelshoj L, Webster P, DHooghe T, Nardone F, De Cicco Nardone C . Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011; 96(2):366-373.e8. PMC: 3679489. DOI: 10.1016/j.fertnstert.2011.05.090. View

Gleicher N, Confino E, Friberg J . Is endometriosis an autoimmune disease?. Obstet Gynecol. 1987; 70(1):115-22. View

Shiina T, Hosomichi K, Inoko H, Kulski J . The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009; 54(1):15-39. DOI: 10.1038/jhg.2008.5. View

Matzaraki V, Kumar V, Wijmenga C, Zhernakova A . The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 2017; 18(1):76. PMC: 5406920. DOI: 10.1186/s13059-017-1207-1. View

Zhou F, Cao H, Zuo X, Zhang T, Zhang X, Liu X . Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease. Nat Genet. 2016; 48(7):740-6. DOI: 10.1038/ng.3576. View

Blais M, Dong T, Rowland-Jones S . HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?. Immunology. 2011; 133(1):1-7. PMC: 3088962. DOI: 10.1111/j.1365-2567.2011.03422.x. View

10.

Ho P, Barton A, Worthington J, Plant D, Griffiths C, Young H . Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2007; 67(5):677-82. PMC: 2563264. DOI: 10.1136/ard.2007.071399. View

11.

Simmonds M, Howson J, Heward J, Carr-Smith J, Franklyn J, Todd J . A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet. 2007; 16(18):2149-53. DOI: 10.1093/hmg/ddm165. View

12.

Paul S, Lal G . The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. Front Immunol. 2017; 8:1124. PMC: 5601256. DOI: 10.3389/fimmu.2017.01124. View

13.

Middleton D, Gonzelez F . The extensive polymorphism of KIR genes. Immunology. 2009; 129(1):8-19. PMC: 2807482. DOI: 10.1111/j.1365-2567.2009.03208.x. View

14.

Falco M, Moretta L, Moretta A, Bottino C . KIR and KIR ligand polymorphism: a new area for clinical applications?. Tissue Antigens. 2014; 82(6):363-73. DOI: 10.1111/tan.12262. View

15.

Kulkarni S, Martin M, Carrington M . The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008; 20(6):343-52. PMC: 3501819. DOI: 10.1016/j.smim.2008.06.003. View

16.

Rajalingam R . Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J Hematol. 2012; 46(4):216-28. PMC: 3259513. DOI: 10.5045/kjh.2011.46.4.216. View

17.

Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T . Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007; 110(1):433-40. PMC: 1896125. DOI: 10.1182/blood-2006-07-038687. View

18.

Graef T, Moesta A, Norman P, Abi-Rached L, Vago L, Older Aguilar A . KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med. 2009; 206(11):2557-72. PMC: 2768862. DOI: 10.1084/jem.20091010. View

19.

Cella M, Longo A, Ferrara G, Strominger J, Colonna M . NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med. 1994; 180(4):1235-42. PMC: 2191670. DOI: 10.1084/jem.180.4.1235. View

20.

Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P . HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Clin Cancer Res. 2013; 19(19):5465-73. DOI: 10.1158/1078-0432.CCR-13-0986. View